Podcasts

Chlorthalidone for Hypertension: Time to Resuscitate an Old, Tried-and-True Agent?

Some say chlorthalidone is superior to hydrochlorothiazide and should be used as first-line therapy in hypertension. A compelling case can be made for resurrecting this venerable drug.

Periprocedural Anticoagulation: Novel Agents, New Rules

Novel anticoagulants (dabigatran, rivaroxaban, apixaban) are gaining wide acceptance over warfarin, for their simplicity of use and proven efficacy.

Statins Linked to Exertional Fatigue in New Study

Statin medications were associated with significant tiredness and exertional fatigue in men and women without cardiovascular disease or diabetes.

Azithromycin Increases Risk of Cardiovascular Death

Azithromycin has been linked to sudden cardiac death in patients with cardiovascular disease that require an antibiotic.

HDL Cholesterol: Why Higher Levels No Longer Equal Lower Risk

A genetic analysis questions the benefits of raising HDL-C levels to reduce the risk of MI and of the value of HDL-C as a surrogate marker of risk.

Antiplatelet Therapy With Aspirin: What Dose in Primary and Secondary Prevention?

Use of aspirin in primary prevention of cardiovascular disease must be based on individual risk-benefit analysis and is not appropriate for patients at low risk.

AIDS and the Empty Nest: Talking Points for HIV-Infected Mothers

For many HIV-positive women, seeing children grow to adulthood has many levels of meaning. In this podcast, a psychologist who has studied many such Moms and their kids has insights for their doctors.

Lung Cancer Screening: New Reasons to Refer

CT screening for lung cancer proves as cost effective as screening for other common cancers. Listen as the head of the study speaks about the new implications for primary care.

Frequent Coffee Consumption Linked to Longevity: Caffeine Buzz

Frequent coffee drinkers have a lower risk than those who drink little or no coffee, of death related to heart and respiratory disease, stroke, and infections.

The New Oral Anticoagulants: Benefits, Risks, Patient Selection

The European Society of Cardiology just weighed in on the 3 new alternatives to warfarin for oral anticoagulation. The response is tempered enthusiasm.